Founded at the Abramson Cancer Center at the University of Pennsylvania

Four-Year Outcomes From a Prospective Phase II Clinical Trial of Moderately Hypofractionated Proton Therapy for Localized Prostate Cancer

Four-Year Outcomes From a Prospective Phase II Clinical Trial of Moderately Hypofractionated Proton Therapy for Localized Prostate Cancer

International Journal of Radiation Oncology, Biology, Physics | 2019

Amardeep S. Grewal, MD; Caitlin Schonewolf, MD; Eun Jeong Min, PhD; Hann-Hsiang Chao, MD; Stefan Both, PhD; Sarah Lam, BS; Susan Mazzoni, MPH; Justin Bekelman, MD; John Christodouleas, MD; Neha Vapiwala, MD